Participations

Paion (Frankfurt : PA8)

http://www.paion.de

Paion est une société biopharmaceutique basée à Aachen, Allemagne. Depuis l’acquisition de CeNes Pharmaceuticals en juin 2008, la société dispose d’un second site à Cambridge, UK.

La société est spécialisée dans le développement et la commercialisation de médicaments innovants pour le traitement en hôpital des désordres du système nerveux central et des maladies cardiaques.


Secteur :	Développement
Localisation :	Aachen, Allemagne

Fonds :	Innoven FCPI 1999, 2000, 2001, 2002, 2003. Innoven Europe, Innoven Europe 2, Innoven Europe 3. FCPI Poste Innovation 1, 2, 3, 5, 6, 9. La Banque Postale Innovation 1.

Contact:	Thomas Balland

Actualités en relation avec :

Paion (Frankfurt : PA8)

19/12/2011

2011-12-19 PAION announces restructuring

paionp-191211

09/11/2011

2011-11-09 PAION AG reports financial results for the first nine months of 2011

paionp091111

09/11/2011

2011-11-09 Consolidated Financial Interim Report for the Third Quarter 2011

paion-300911

29/08/2011

2011-08-29 PAION STARTS PHASE Ib STUDY IN HAEMOPHILIA WITH SOLULIN

paion-290811

27/09/2010

2010-09-27 Paion Completes pahse IIB Study With Short-Acting Anesthetic-Sedative Remimazolam

2010-09-27_paion-completes-pahse-iib-study-with-short-acting-anesthetic-sedative-remimazolam

20/10/2009

2009-10-06 Paion Announces Completion Of Phase IB Study With Its Short Acting Anesthetic-Sedative CNS 7056

2009-10-06_paion-announces-completion-of-phase-ib-study-with-its-short-acting-anesthetic-sedative-cns-7056

20/10/2009

2009-10-05 Abstract On CNS 7056 Has Been Chosen As One Of The Best Abstracts By The American Society Of Anesthesiologists

2009-10-05_paion-abstract-on-cns-7056-has-been-chosen-as-one-of-the-best-abstracts-by-the-american-society-of-anesthesiologists

08/09/2009

2009-09-08 PAION announces patient recruitment for phase IIa study with its short acting anesthetic/sedative CNS 7056 successfully completed

2009-09-08_-paion-announces-patient-recruitment-for-phase-iia-study-with-its-short-acting-anesthetic-sedative-cns-7056-successfully-completed

05/08/2009

2009-08-05 Paion AG reports results for the first half year 2009

2009-08-05-paion-ag-reports-results-for-the-first-half-year-2009

16/07/2009

2009-07-15 PAION: Phase Ib and IIa studies of the anesthetic/sedative CNS 7056 on track

2009-07-15_paion-phase-ib-and-iia-studies-of-the-anesthetic-sedative-cns-7056-on-track

26/05/2009

2009-05-13 Paion AG Reports Results for the First Quarter 2009

2009-05-13_paion-ag-reports-results-for-the-first-quarter-2009

26/05/2009

2009-05-11 Paion completes first part of phase Ib Study of the Anesthetic/Sedative CNS 7056

2009-05-11_paion-completes-first-part-of-phase-ib-study-of-the-anesthetic-sedative-cns-7056

20/04/2009

2009-04-20 PAION Initiates Phase Ib Study Of The Anesthetic/Sedative CNS 7056 in Volunteers Undergoing Colonoscopy

PAION Initiates Phase Ib Study Of The Anesthetic/Sedative CNS 7056 in Volunteers Undergoing Colonoscopy

15/04/2009

2009-04-15 Paion Initiates Phase II Trial With Its Anesthethic/Sedative CNS 7056

Paion Initiates Phase II Trial With Its Anesthethic/Sedative CNS 7056

09/04/2009

2009-04-09 PAION and ERGOMED Report Full Data of CNS 5161 Phase IIa Study in Neuropathic Cancer Pain

PAION and ERGOMED Report Full Data of CNS 5161 Phase IIa Study in Neuropathic Cancer Pain

Innoven Partenaires est une société de gestion en capital investissement spécialisée dans la gestion de FCPI. Notre approche est de faire progresser les actifs confiés par tous les moyens qu’offrent le capital investissement. Pas encore inscrit ? Vous trouverez toutes les informations de souscription à nos FCPI sur notre page souscripteurs.

© Copyright 2012 - Innoven Partners